Management of recurrent or metastatic thyroid cancer von Tahara, Makoto

Volltext

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck von Ferris, Robert L, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin, Kasper, Stefan, Vokes, Everett E, Even, Caroline, Worden, Francis, Saba, Nabil F, Iglesias Docampo, Lara C, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Monga, Manish, Lynch, Mark, Geese, William J, Kopit, Justin, Shaw, James W, Gillison, Maura L

Volltext

Management of VEGFR-Targeted TKI for Thyroid Cancer von Enokida, Tomohiro, Tahara, Makoto

Volltext

A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma von Tahara, Makoto, Okano, Susumu, Enokida, Tomohiro, Ueda, Yuri, Fujisawa, Takao, Shinozaki, Takeshi, Tomioka, Toshifumi, Okano, Wataru, Biel, Merrill A., Ishida, Kosuke, Hayashi, Ryuichi

Volltext

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer von Schlumberger, Martin, Tahara, Makoto, Wirth, Lori J, Robinson, Bruce, Brose, Marcia S, Elisei, Rossella, Habra, Mouhammed Amir, Newbold, Kate, Shah, Manisha H, Hoff, Ana O, Gianoukakis, Andrew G, Kiyota, Naomi, Taylor, Matthew H, Kim, Sung-Bae, Krzyzanowska, Monika K, Dutcus, Corina E, de las Heras, Begoña, Zhu, Junming, Sherman, Steven I

Volltext

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer von Kiyota, Naomi, Schlumberger, Martin, Muro, Kei, Ando, Yuichi, Takahashi, Shunji, Kawai, Yasukazu, Wirth, Lori, Robinson, Bruce, Sherman, Steven, Suzuki, Takuya, Fujino, Katsuki, Gupta, Anubha, Hayato, Seiichi, Tahara, Makoto

Volltext

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Me... von Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Castro, Ana, Licitra, Lisa, Adelstein, David, Vermorken, Jan B.

Volltext

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies von Mehanna, Hisham, Rischin, Danny, Wong, Stuart J, Gregoire, Vincent, Ferris, Robert, Waldron, John, Le, Quynh-Thu, Forster, Martin, Gillison, Maura, Laskar, Sarbani, Tahara, Makoto, Psyrri, Amanda, Vermorken, Jan, Porceddu, Sandro

Volltext

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651 von Haddad, Robert I, Harrington, Kevin, Tahara, Makoto, Ferris, Robert L, Gillison, Maura, Fayette, Jerome, Daste, Amaury, Koralewski, Piotr, Zurawski, Bogdan, Taberna, Miren, Saba, Nabil F, Mak, Milena, Kawecki, Andrzej, Girotto, Gustavo, Alvarez Avitia, Miguel Angel, Even, Caroline, Toledo, Joaquin Gabriel Reinoso, Guminski, Alexander, Müller-Richter, Urs, Kiyota, Naomi, Roberts, Mustimbo, Khan, Tariq Aziz, Miller-Moslin, Karen, Wei, Li, Argiris, Athanassios

Volltext

Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer von Licitra, Lisa, Keilholz, Ulrich, Tahara, Makoto, Lin, Jin-Ching, Chomette, Pauline, Ceruse, Philippe, Harrington, Kevin, Mesia, Ricard

Volltext

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors von Doz, François, van Tilburg, Cornelis M, Geoerger, Birgit, Højgaard, Martin, Øra, Ingrid, Boni, Valentina, Capra, Michael, Chisholm, Julia, Chung, Hyun Cheol, DuBois, Steven G, Gallego-Melcon, Soledad, Gerber, Nicolas U, Goto, Hiroaki, Grilley-Olson, Juneko E, Hansford, Jordan R, Hong, David S, Italiano, Antoine, Kang, Hyoung Jin, Nysom, Karsten, Thorwarth, Anne, Stefanowicz, Joanna, Tahara, Makoto, Ziegler, David S, Gavrilovic, Igor T, Norenberg, Ricarda, Dima, Laura, De La Cuesta, Esther, Laetsch, Theodore W, Drilon, Alexander, Perreault, Sebastien

Volltext

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance von Tahara, Makoto, Kiyota, Naomi, Nibu, Ken-ichi, Akamatsu, Ayumi, Hoshino, Tomohiro, Hayashi, Ryuichi

Volltext

Immunotherapy for squamous cell carcinoma of the head and neck von Yokota, Tomoya, Homma, Akihiro, Kiyota, Naomi, Tahara, Makoto, Hanai, Nobuhiro, Asakage, Takahiro, Matsuura, Kazuto, Ogawa, Takenori, Saito, Yuki, Sano, Daisuke, Kodaira, Takeshi, Motegi, Atsushi, Yasuda, Koichi, Takahashi, Shunji, Tanaka, Kaoru, Onoe, Takuma, Okano, Susumu, Imamura, Yoshinori, Ariizumi, Yosuke, Hayashi, Ryuichi

Volltext

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck von Argiris, Athanassios, Harrington, Kevin J, Tahara, Makoto, Schulten, Jeltje, Chomette, Pauline, Ferreira Castro, Ana, Licitra, Lisa

Volltext

Treatment‐emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT) von Wirth, Lori J., Tahara, Makoto, Robinson, Bruce, Francis, Sanjeev, Brose, Marcia S., Habra, Mouhammed Amir, Newbold, Kate, Kiyota, Naomi, Dutcus, Corina E., Mathias, Elton, Guo, Matthew, Sherman, Steven I., Schlumberger, Martin

Volltext

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma von Hara, Hiroki, Tahara, Makoto, Daiko, Hiroyuki, Kato, Ken, Igaki, Hiroyasu, Kadowaki, Shigenori, Tanaka, Yoichi, Hamamoto, Yasuo, Matsushita, Hisayuki, Nagase, Michitaka, Hosoya, Yoshinori

Volltext

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based t... von Machiels, Jean-Pascal H, Prof, Haddad, Robert I, MD, Fayette, Jérôme, MD, Licitra, Lisa F, MD, Tahara, Makoto, MD, Vermorken, Jan B, Prof, Clement, Paul M, Prof, Gauler, Thomas, MD, Cupissol, Didier, MD, Grau, Juan José, MD, Guigay, Joël, Prof, Caponigro, Francesco, MD, de Castro, Gilberto, PhD, de Souza Viana, Luciano, MD, Keilholz, Ulrich, Prof, del Campo, Joseph M, MD, Cong, Xiuyu Julie, PhD, Ehrnrooth, Eva, MD, Cohen, Ezra E W, MD

Volltext

Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma von Maruo, Takashi, Zenda, Sadamoto, Shinozaki, Takeshi, Tomioka, Toshifumi, Okano, Wataru, Sakuraba, Minoru, Tahara, Makoto, Hayashi, Ryuichi

Volltext

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 rando... von Vermorken, Jan B, Dr, Stöhlmacher-Williams, Jan, MD, Davidenko, Irina, MD, Licitra, Lisa, MD, Winquist, Eric, MD, Villanueva, Cristian, MD, Foa, Paolo, MD, Rottey, Sylvie, MD, Skladowski, Krzysztof, MD, Tahara, Makoto, MD, Pai, Vasant R, MD, Faivre, Sandrine, MD, Blajman, Cesar R, MD, Forastiere, Arlene A, MD, Stein, Brian N, MBBS, Oliner, Kelly S, PhD, Pan, Zhiying, PhD, Bach, Bruce A, MD

Volltext

Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized... von Haddad, Robert, Concha‐Benavente, Fernando, Blumenschein, George, Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Kasper, Stefan, Vokes, Everett E., Worden, Francis, Saba, Nabil F., Tahara, Makoto, Jayaprakash, Vijayvel, Lynch, Mark, Li, Li, Gillison, Maura L., Harrington, Kevin J., Ferris, Robert L.

Volltext